Oncology Revenue Cycle Management Software for Cancer Care
Connect prior authorization, coding, claims, payments, and denials
QuickIntell is workflow software for oncology practices and cancer programs. It supports AI-assisted repeat-cycle authorizations, drug and infusion coding, claim status, remittance, denials, and appeals. Staff can review high-impact actions and exceptions before data moves into a payer channel or the EHR.
Oncology RCM workflow
How oncology revenue cycle management moves from coverage to payment
Cancer care creates repeat-cycle administrative dependencies: benefits, regimen evidence, approved units, drug coding, claim status, and remittance all need to stay aligned. QuickIntell connects eligibility, prior authorization, medical coding, claims, payment posting, denial work, and analytics around a shared case trail.
Step 1
Eligibility Verification
270/271 responses bring active coverage, benefits, service-type details, and payer notes into the work queue before treatment-related billing begins.
Step 2
Prior Authorization
Staff review regimen, diagnosis, requested units, dates, and supporting records before a 278, portal, or fax submission moves forward.
Step 3
Medical Coding & Charge Capture
Teams review documented services, CPT, ICD-10, HCPCS, modifiers, J-codes, NDC detail, quantities, and charge completeness.
Step 4
Claims
Reviewed claim data moves into 837 submission, acknowledgement, rejection handling, and 277 status follow-up without losing authorization context.
Step 5
Payment Posting
835 ERA files match to source claims; configured items can post while exceptions and high-impact adjustments remain available for staff review.
Step 6
Denial Management & Appeals
CARC/RARC outcomes become owned cases with filing dates, authorization history, supporting records, and escalation paths for correction or appeal.
Step 7
Analytics
Teams can review payer, provider, code, authorization, denial, payment, and work-queue patterns against the underlying records.
Prior authorization deep dive
Chemo, biologic, infusion, and renewal authorizations in one queue
Oncology PA work is high-dollar and deadline-sensitive. Prior Authorization brings packet inputs, payer-channel status, renewal dates, and exceptions into one queue. Approved authorization details can move through configured EHR Integration after staff review.
The path covers 278 EDI, portal, and fax workflows: assemble the packet, validate fields, choose a submission channel, monitor status, route portal exceptions, prepare P2P or appeal work, and carry reviewed units and effective dates into billing.
Chemo and biologic PA packets
Assemble diagnosis, regimen, planned CPT/HCPCS, J-code, NDC, units, site of care, labs, pathology, imaging, and prior-therapy history in one review queue.
Supporting documentation control
Collect treatment plans, pathology or imaging, biomarker results, prior-treatment history, and payer-required forms in the same review context.
Renewal calendar
Track expiring authorizations for recurring cycles, maintenance biologics, injectable drugs, and supportive meds before effective dates lapse.
P2P and appeal path
Prepare peer-to-peer and appeal materials, keep filing dates visible, and require the appropriate staff or clinician to review before submission.
Coding and claims deep dive
Review drug, dose, units, diagnosis, and claim status in sequence
QuickIntell keeps the coded encounter, claim scrub, 837 submission, 277 status, and remittance handoff tied together with Claims so staff can investigate failed checks and payer responses in context.
Oncology code review
Review CPT, ICD-10, HCPCS, modifiers, diagnosis pointers, J-code and NDC detail, units, route, dose, and documented wastage before release.
Eight-stage claim scrub
Run NCCI, MUE, medical-necessity, LCD/NCD, frequency, bundling, documentation, and modifier checks; failed findings stay in review.
837 and 277 status trail
Carry authorization detail into professional or institutional 837 files, then keep acknowledgements, rejections, and 277 status visible to billers.
835 denial handoff
Match ERA results to the originating claim and route CARC/RARC outcomes, unmatched items, or reimbursement variances to the right queue.
Reviewed denial outcomes can inform configurable coding, authorization, and claim-scrub rules, including CARC/RARC trends, missing-authorization patterns, documentation gaps, and drug-code or unit mismatches.
Denial prevention and management
Turn CARC/RARC outcomes into owned oncology work queues
QuickIntell turns remittance outcomes into structured cases and can use reviewed patterns to flag similar risk before submission. Staff route appealable work through denial management with the claim, authorization history, filing date, and supporting records together.
CARC/RARC case workflow
835 ERA adjustments create denial cases with payer, provider, CPT, drug, denied amount, CARC/RARC reason, filing deadline, and owner in one work queue.
Missing-auth and medical-necessity examples
Oncology teams can separate absent auth numbers, expired approvals, approved-unit mismatches, missing pathology, weak regimen rationale, and documentation gaps before appeal work starts.
Pre-submission risk review
Denial Prevention rules can flag configured authorization, coding, medical-necessity, timely-filing, bundling, and payer risks before release.
Appeal preparation and escalation
Payer, code, drug, provider, and denial context helps staff choose correction, retro-authorization, peer-to-peer preparation, appeal review, or approval-gated write-off.
Common oncology examples include missing authorization on an infusion series, medical-necessity denials where regimen rationale or pathology support is absent, payer policy shifts by drug or site of care, and partial approvals that need P2P or appeal review before the applicable filing date.
Payment posting and analytics
Reconcile 835 payments, exceptions, and reimbursement variance
Oncology billing needs a clear trail from 837 submission through 835 remittance. QuickIntell ties payment posting, adjustments, denials, and follow-up outcomes back to source claims, authorizations, and encounters, with exceptions available for human review.
ERA matching and exceptions
835 files match to source claims; configured items can post, while unmatched payments, refunds, denials, and high-impact adjustments enter exception review.
Revenue Integrity review
Configured expected reimbursement can be compared with payer remittance so oncology drug, infusion, and other service variances are visible for investigation.
Analytics for follow-up
Dashboards connect posting, denial, appeal, and follow-up outcomes by payer, provider, authorization status, code, drug detail, and days in AR.
Integration and implementation
Phase oncology RCM around your EHR, payer mix, and review policies
EHR Integration can supply patient, coverage, appointment, encounter, and charge context to the workflow. Scope, field mappings, write-back, payer channels, and approval rules are validated before broader automation.
Phase 1
Map the current workflow
Confirm the EHR, payer channels, oncology service lines, data owners, authorization inputs, claim types, and exception paths in scope.
Phase 2
Validate in review mode
Test field mappings, sample authorizations or claims, role permissions, status updates, and write-back behavior with staff approval enabled.
Phase 3
Phase automation by risk
Move only agreed steps beyond review mode, train queue owners, monitor exceptions, and keep escalation or rollback paths clear.
Trust and security
Human review and access controls for PHI workflows
QuickIntell keeps review gates available for high-impact actions and exceptions. Review the broader operating safeguards in the QuickIntell Trust Center.
Role-Based Access Control for the queues, records, and actions assigned to each job function.
Organization-scoped records keep connected workflow data within the configured tenant boundary.
Protected credential handling for payer portals and configured integrations.
Audit logs for claim edits, denial decisions, appeal activity, write-offs, and EHR write-back.
Approval gates for overrides, appeals, payments, and other high-impact workflow changes.
Exception queues and manual completion paths when automation cannot safely finish a payer or EHR step.
Practical RCM review guide
Oncology charge review: reconcile each administered treatment
QuickIntell Editorial Team · Guide updated
Use the administered treatment record as the anchor for oncology charge review. The ordered regimen, supplied drug, payer response, and actual administration can diverge; an unchanged appointment does not establish an unchanged billing record.
Review step 1
Version regimen changes
Keep drug, dose, schedule, site, and benefit-routing changes attached to the treatment cycle. Send differences from the existing payer response to an authorization reviewer before reusing that response.
Review step 2
Reconcile drug quantities
Compare acquisition and container information with the authenticated administration and discard record. Have the coding team resolve unit conversions, package scope, and any missing documentation instead of deriving discarded amounts from a default percentage.
Review step 3
Close the payment exception
Link each remittance issue to the corresponding drug or administration line, source record, and responsible owner. Distinguish an unpaid drug line from an administration-code issue so follow-up addresses the actual discrepancy.
Measure your own pilot
Measure quantity-related clarifications and treatment cycles with unresolved authorization changes. Report correction time and exception age separately from collections; this avoids presenting the value of a high-cost drug as an automation saving.
Inspect line-level payment exception handlingSource scope and review limits
CMS JW/JZ reporting applies to specified single-dose containers or single-use packages separately payable under Medicare Part B, not every drug claim.
These are editorial workflow recommendations, not clinical advice, claim-specific coding instructions, verified customer results, or an attestation by a credentialed reviewer. Validate current payer rules, licensed code references, and local approvals before use.
CMS coding and coverage reference
Oncology billing guidelines: NCCI edits and Medicare coverage
In the CMS NCCI practitioner and ASC procedure-to-procedure table, version v323r0 (2026 Q4), 105 codes in the oncology ranges listed below are column one in 16,005 active pairs, and 56% of those pairs carry modifier indicator 1, so an NCCI-associated modifier can bypass the edit when the record supports a distinct service. The hospital outpatient table holds 6,233 pairs for the same codes. The 2026 Q4 practitioner Medically Unlikely Edit table sets a value for 306 codes in these ranges, all of them applied per date of service, and 82 of the values allow a single unit. 16 codes in the ranges are add-on codes that must be billed with a primary procedure. The most frequent edit rationale is “Standards of medical/surgical practice” (7,097 pairs).
Code ranges counted: 96360-96549 (infusion, injection and chemotherapy administration); 77261-77799 (radiation oncology); J9000-J9999 (chemotherapy drugs). The ranges are our selection of where oncology services sit in the code set, not a CMS classification.
What the 2026 NCCI Policy Manual says
Only one initial administration code is reported per encounter unless separate intravenous sites are medically necessary, flushing a port before or after drug administration is part of the service, and 96368 is limited to one unit per encounter. Apart from the visit at which radiation therapy is decided, evaluation and management is generally not reported separately with radiation oncology services.
- Chapter XI: Medicine and Evaluation and Management Services · sections N (Chemotherapy Administration), B (Therapeutic or Diagnostic Infusions/Injections and Immunizations) · CPT 90000-99999 CMS PDF
- Chapter IX: Radiology Services · section F (Radiation Oncology) · CPT 70000-79999 CMS PDF
Most-bundled column-two codes inside these ranges
Each code is the column-two code in this many active practitioner pairs whose column-one code is also in the ranges. Open one in the NCCI checker to see its pairs and modifier indicators.
Local coverage topics
National coverage determinations
- Erythropoiesis Stimulating Agents (ESAs) in Cancer and Related Neoplastic Conditions · NCD 110.21
- Aprepitant for Chemotherapy-Induced Emesis · NCD 110.18
- Chimeric Antigen Receptor (CAR) T-cell Therapy · NCD 110.24
- Next Generation Sequencing (NGS) · NCD 90.2
- Positron Emission Tomography (FDG) for Oncologic Conditions · NCD 220.6.17
Codes, drug classes and payment groups
- Chemotherapy drug codes (J9000-J9999) · 179 HCPCS codes
- Biosimilar drug codes · 55 HCPCS codes
- Drugs administered other than oral method, chemotherapy drugs (J codes) · 847 HCPCS codes
- MDC 17: Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms · 28 MS-DRGs
- CMS-HCC V28 cancer categories · 7 payment HCCs
- ASP payment limits for chemotherapy drugs
- JW and JZ for discarded drug amounts
Sources: CMS Medicare NCCI Policy Manual (2026 edition) and the quarterly NCCI procedure-to-procedure, Medically Unlikely Edit and add-on code files, edit version v323r0 (2026 Q4) effective 2026-10-01; counts computed by QuickIntell from those files, see the methodology. CPT codes are shown as numbers only; CPT is a registered trademark of the American Medical Association. A summary for orientation, not billing or legal advice: check the CMS text and your Medicare Administrative Contractor before you code.
Oncology Revenue Cycle Management FAQs
Answers for oncology operations, billing, and IT teams evaluating authorization evidence, EHR connectivity, claim review, denials, and implementation.
Oncology revenue cycle management coordinates the administrative and financial work around cancer care, from coverage and regimen authorization through charge capture, coding, claims, payment posting, denials, and appeals. It is especially dependent on treatment-specific evidence, approved dates and units, drug billing detail, recurring-cycle renewals, and a clear handoff between clinical, authorization, and billing teams.
Requirements vary by payer and treatment, but the review packet may need the diagnosis, stage, line of therapy, regimen, dose and units, site of care, pathology or imaging, biomarker results, prior-treatment history, response or failure details, and payer forms. QuickIntell keeps these inputs with the authorization record so staff can verify the packet before submission and add updated evidence for a renewal.
QuickIntell supports authorization work queues for chemotherapy, biologics, specialty drugs, infusions, imaging, and recurring treatment cycles. Staff can validate payer-required fields, choose an EDI 278, portal, or fax path, monitor status, review partial decisions, prepare peer-to-peer or appeal work, and create renewal drafts. The workflow supports the process; it does not guarantee payer approval.
QuickIntell connects to supported EHRs through FHIR, REST, and configured adapters. Field mappings determine which patient, coverage, appointment, encounter, authorization, and charge details move in each direction. Teams can test write-back in review mode, and portal or integration exceptions can route to a manual completion path instead of silently changing a source record.
Medical Coding can propose CPT, ICD-10, HCPCS, modifiers, and drug-billing detail, then run NCCI, MUE, medical-necessity, LCD/NCD, frequency, bundling, documentation, and modifier checks. Failed findings remain visible for coder review. Staff accept, edit, or clarify the result before sending it to the claim editor, so the software does not promise error-free coding.
CARC/RARC outcomes can open tracked cases with the claim, authorization history, payer reason, filing date, owner, and supporting records together. Staff decide whether the next step is a coding correction, retro-authorization request, peer-to-peer preparation, appeal review, or an approval-gated write-off. Reviewed outcomes can also inform future Denial Prevention rules without guaranteeing that a similar claim will be paid.
Scope depends on the EHR, payer mix, service lines, claim types, and review policies. A typical sequence is workflow discovery, connection and field mapping, role and security review, sample authorization or claim validation, staff training, and monitored go-live. Automation can begin in review-only mode and expand by workflow only after the team confirms mappings, payer behavior, exception ownership, and rollback steps.
Have a payer, regimen, or claim workflow you want to map?
Contact Our Oncology RCM TeamMap Your Oncology Revenue Cycle Workflow
Bring one representative payer, regimen, or claim workflow. The QuickIntell team can map its data inputs, staff review gates, payer channels, EHR write-back, exception ownership, and phased rollout across eligibility, authorization, coding, claims, payment posting, denials, and appeals.
Visit the QuickIntell Website
quickintell.comEmail Our RCM Team
info@quickintell.comSchedule Oncology RCM Consultation
Personalized demo and consultation for oncology practices with workflow mapping, review policies, and integration scope
